,
your personalized virtual assistant to find clinical trials. Go head, 
William F. Demas, MD
Barberton Citizens HospitalBarberton, Ohio - 44203 (330-375-3557) |
- CLINICAL TRIALS 21
- CONDITIONS23
- INTERVENTIONS54
- SINCE2004
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
November 2009 - April 2015
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
September 2009 - August 2015
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
November 2009 - June 2015
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
March 2010 - April 2012
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
February 2010 - October 2010
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
March 2008 - October 2008
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
March 2008 - May 2012
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
April 2009 - April 2010
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate Cancer
February 2008 - December 2017
Paclitaxel Cisplatin and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
June 2008 - December 2015
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
November 2007 - January 2014
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
September 2009 - December 2014
Single-Fraction Compared With Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases
January 2004 - June 2013
Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer
April 2008 - October 2012
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
July 2005 - July 2012
Radiation Therapy and Cisplatin in Treating Patients With Stage I Bladder Cancer
November 2009 - September 2012
Observation or Radiation Therapy in Treating Patients With Grade I Grade II or Grade III Meningioma
June 2009 - August 2009
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010
Intensity-Modulated Radiation Therapy Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
November 2009 - May 2010
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
July 2010 - July 2013
Lung Neoplasms
Nervous System Neoplasms
Central Nervous System Neoplasms
Lymphoma
Adenocarcinoma
Prostatic Neoplasms
Neoplasm Metastasis
Urinary Bladder Neoplasms
Pancreatic Neoplasms
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Esophageal Diseases
Esophageal Neoplasms
Bone Neoplasms
Bone Marrow Diseases
Glioblastoma
Carcinoma, Small Cell
Meningioma
Endometrial Neoplasms
Uterine Cervical Neoplasms
Hodgkin Disease
Colorectal Neoplasms
Radiation Injuries
Placebo
Intensity-Modulated Radiation Therapy
Computed Tomography
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Study Of Socioeconomic And Demographic Variables
Fludeoxyglucose F 18
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Fluorouracil
Leucovorin Calcium
Erlotinib Hydrochloride
Gemcitabine Hydrochloride
Gene Expression Analysis
Polymorphism Analysis
Adjuvant Therapy
Cyclophosphamide
Prednisone
Radiation Therapy
Cediranib Maleate
Temozolomide
Capecitabine
3-Dimensional Conformal Radiation Therapy
Doxorubicin Hydrochloride
Etoposide
Vincristine Sulfate
Polymerase Chain Reaction
Vinblastine Sulfate
Bicalutamide
Buserelin
Flutamide
Goserelin
Leuprolide Acetate
Triptorelin
Trastuzumab
Mutation Analysis
Cetuximab
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Irinotecan Hydrochloride
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Prophylactic Cranial Irradiation
Selective External Radiation Therapy
Dacarbazine
Clinical Observation
Bleomycin Sulfate
Abvd Regimen
Beacopp Regimen
Procarbazine Hydrochloride
Samarium Sm 153 Lexidronam Pentasodium
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique
